Stocks
CONMED (CNMD) EV/EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 34.8 | 30.3 | 473.0 | 16.5 | 23.7 | 16.8 | ||
| Changes by years, y/y, % | +11% | -13% | +1 462% | -97% | +44% | -5.5% | |||
CONMED. EV/EBITDA
CONMED. EV/EBITDA, changes, %
CONMED (CNMD) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | 26.3 | 33.0 | 19.7 | 15.9 | 13.6 | 16.8 | |
| Changes by years, y/y, % | -130% | -137% | -124% | -81% | -77% | |||
| Changes by quarters, q/q, % | -55% | +26% | -40% | -19% | -14% | |||
